|
Volumn 19, Issue 1, 2010, Pages
|
Preface
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMATINIB;
PLACEBO;
SORAFENIB;
ADVANCED CANCER;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER RESEARCH;
CANCER SURVIVAL;
CLINICAL STUDY;
CLINICAL TRIAL;
COLON CANCER;
COLON RESECTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG APPROVAL;
EDITORIAL;
FOLLOW UP;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
LAPAROSCOPIC SURGERY;
LIVER CELL CARCINOMA;
LYMPHADENECTOMY;
MELANOMA;
METASTASIS;
PANCREAS CANCER;
PANCREATICODUODENECTOMY;
PRACTICE GUIDELINE;
PROGNOSIS;
PROSTATECTOMY;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL;
SALVAGE THERAPY;
SOLID TUMOR;
STANDARD;
STOMACH CANCER;
SURGICAL TRAINING;
ARTICLE;
NEOPLASM;
ONCOLOGY;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
EID: 70449732311
PISSN: 10553207
EISSN: None
Source Type: Journal
DOI: 10.1016/j.soc.2009.09.014 Document Type: Editorial |
Times cited : (2)
|
References (1)
|